Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Clinical trial NCT05350774 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05350774
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-10
- Primary completion
- 2026-12-15
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.